维普中文期刊产品整合服务
17篇 您的检索式:作者名="PatilA"
    题名 作者 年代 出处 被引量
1Ligation of ameroid-stenosed coronary artery leads to reproducible myocar- dial infarction--a pilot study in a porcine model显示文摘IKONEN TS PATILA T VIRTANEN K 2007J Surg Res2007,142,1:1
2Vas- cular endothelial growth factor C-induced collateral formation in a model of myocardial ischemia 显示文摘PATILA T IKONEN T RUTANEN J AHONEN A 2006J Heart Lung Transplant2006,25,2:1
3Phytochemical screening, and evaluation of antibacterial, antioxidant and cytotoxic activity of Ficuz racemosa Linn显示文摘Kambli J PatilA Chithrashree 2014Int J Clin Pharm Net2014,6,4:1
4Central nervous system involvement and the role of prophylactic cranial irradiation in small cell lung cancer显示文摘Alexopoulos CG Vaslarnltzis M Patila E 1997Oncologist1997,2,:1
5Air toxics in ambient air of Delhi显示文摘Srivastavaa A Josepha A E Patila S 2005Atmos Environ2005,39,1:1
6显示文摘Shukla S Patila S 2004Journal of Nanoscience and Nanotechnology2004,4,1:1
7Evaluation of acrylamide-grafted-xanthan gum copolymer matrix tablets for oral controlled delivery of antihypertensive drugs显示文摘MUNDARGIA R C PATILA S A AMINABHAVI T M 2007Carbohydrate Polymers2007,69,1:1
8Polyglycolic acid glue does not prevent intrapericardial adhesions in a short - term follow - up 显示文摘Patila T Jokinen JJ Salminen J 2008JSurgRes2008,148,:1
9Modulation of stress induced by isometric hand- grip test in hypertensive patients following yogic; Relax- ation training 显示文摘VIJAYALAKSHM P MADANMOHAN BHAVANANIAB PATILA 2004Indian Physiol Phamacol2004,4,8:1
10GeneticexpressionofMMP-Matrix-mettalo-proteinases(MMP-1andMMP-13)asafunctionofanteriormandibularrepositioningapplianceonthegrowthofmandibularcondylarcartilagewithandwith-outadministrationofInsulinlikegrowthfactor(IGF-1)andTransforminggrowthfactor-B (TGF-β)显示文摘PatilA SableR KothariR 2012AngleOrthod2012,82,6:1
11Room temperature hydrogen gas sensitivity of nanocrstalline pure tin oxide显示文摘Shukla S Patila S 2004Jonmal of Nanoseienee and Nanotechnology2004,4,1:1
12Epoxidation of styrene by anhydrous H2O2 over TS-1 and γ-Al2O3 catalysts: effect of reaction water, poisoning of acid sites and presence of base in the reaction mixture显示文摘Choudhary V R Patila N S Bhargava S K 2003Catalysis Letters2003,89,1:1
13Air toxics in ambient air of Delhi显示文摘Srivatava A Jose Pha A E Patila S 2005Atmospheric Environment2005,39,:1
14Prospective, randomized, double-blinded trial of bone marrow cell transplantation combined with coronary surgery-perloperatlve safety study 显示文摘Lehtinen M Patila T Vento A 2014Interact Card- iovasc Thorac Surg2014,19,6:1
15Advances in cell transplantation therapy for diseased myocardium 显示文摘Villet OM Siltanen A Patila T 2011Stem Cells lnt2011,2011,67:1
16Technical note for intraoperative determination of proper acetabular cup size in primary total hip arthroplasty显示文摘BACKGROUND Selecting the optimal size of components is crucial when performing a primary total hip arthroplasty.Implanting the accurate size of the acetabular component can occasionally be exacting,chiefly for surgeons with little experience,whilst the complications of imprecise acetabular sizing or over-reaming can be potentially devastating.AIM To assist clinicians intraoperatively with a simple and repeatable tip in elucidating the ambivalence when determining the proper acetabular component size is not straightforwardly achieved,specifically when surgeons are inexperienced or preoperative templating is unavailable.METHODS This method was employed in 263 operations in our department from June 2021 to December 2022.All operations were performed by the same team of joint reconstruction surgeons,employing a typical posterior hip approach technique.The types of acetabular shells implanted were:The Dynasty®acetabular cup system(MicroPort Orthopedics,Shanghai,China)and the R3®acetabular system(Smith&Nephew,Watford,United Kingdom),which both feature cementless press-fit design.RESULTS The mean value of all cases was calculated and collated with each other.We distinguished as oversized an implanted acetabular shell when its size was>2 mm larger than the size of the acetabular size indicator reamer(ASIR)or when the implanted shell was larger than 4 mm compared to the preoperative planned cup.The median size of the implanted acetabular shell was 52(48–54)mm,while the median size of the preoperatively planned cup was 50(48–56)mm,and the median size of the ASIR was 52(50–54)mm.The correlation coefficient between ASIR size and implanted acetabular component size exhibited a high positive correlation with r=0.719(P<0.001).Contrariwise,intraoperative ASIR measurements precisely predicted the implanted cups’size or differed by only one size(2 mm)in 245 cases.CONCLUSION In our study,we demonstrated that the size of the first acetabular reamer not entering freely in the acetabular rim corroborates the final acetabular component size to implant.This was also corresponding in the majority of the cases with conventional preoperative templating.It can be featured as a valid tool for avoiding the potentially pernicious complications of acetabular cup over-reaming and over-sizing in primary total hip arthroplasty.It is a simple and reproducible technical note useful for confirming the predicted acetabular cup size preoperatively;thus,its application could be considered routinely,even in cases where preoperative templating is unavailable.Panagiotis Karampinas John Vlamis Athanasios Galanis Michail Vavourakis Anastasia Krexi Evangelos Sakellariou Christos Patilas Spiros Pneumaticos 2024World Journal of Methodology2024,14,1:0
17Trends of nanotechnology in type 2 diabetes mellitus treatment显示文摘There are several therapeutic approaches in type 2 diabetes mellitus(T2DM).When diet and exercise fail to control hyperglycemia,patients are forced to start therapy with antidiabetic agents.However,these drugs present several drawbacks that can affect the course of treatment.The major disadvantages of current oral modalities for the treatment of T2DM are mainly depicted in the low bioavailability and the immediate release of the drug,generating the need for an increase in frequency of dosing.In conjugation with the manifestation of adverse side effects,patient compliance to therapy is reduced.Over the past few years nanotechnology has found fertile ground in the development of novel delivery modalities that can potentially enhance anti-diabetic regimes efficacy.All efforts have been targeted towards two main vital steps:(a)to protect the drug by encapsulating it into a nano-carrier system and(b)efficiently release the drug in a gradual as well as controllable manner.However,only a limited number of studies published in the literature used in vivo techniques in order to support findings.Here we discuss the current disadvantages of modern T2DMmarketed drugs,and the nanotechnology advances supported by in vivo in mouse/rat models of glucose homeostasis.The generation of drug nanocarriers may increase bioavailability,prolong release and therefore reduce dosing and thus,improve patient compliance.This novel approach might substantially improve quality of life for diabetics.Application ofmetal nanoformulations as indirect hypoglycemic agents is also discussed.Yannis V.Simos Konstantinos Spyrou Michaela Patila Niki Karouta Haralambos Stamatis Dimitrios Gournis Evangelia Dounousi Dimitrios Peschos 2021Asian Journal of Pharmaceutical Sciences2021,16,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费